Target Name: BDP1
NCBI ID: G55814
Review Report on BDP1 Target / Biomarker Content of Review Report on BDP1 Target / Biomarker
BDP1
Other Name(s): DFNB112 | Transcription factor-like nuclear regulator | transcription factor IIIB 150 | TFIIIB150 | TFIIIB' | Transcription factor TFIIIB component B'' homolog | Transcription factor IIIB 150 | transc

BDP1:Regulating Apoptosis and Cell Survival

BDP1 (Bcl-2-associated protein 1) is a protein that is expressed in a variety of tissues throughout the body, including the brain, spleen, and gastrointestinal tract. It is a member of the Bcl-2 family of proteins, which are known for their ability to regulate apoptosis, or programmed cell death. BDP1 is also known as DFNB112, which stands for double-stranded nucleotide-binding protein 112.

The Bcl-2 family of proteins are known for their role in protecting cells from apoptosis, which is a natural response of cells to DNA damage or other stressors. In many cases, this protection is essential for the survival of the cell. However, in some cases, apoptosis can be a healthy and necessary part of the cell's response to stress. BDP1 is involved in these processes, and is thought to play a role in the regulation of apoptosis.

One of the key functions of BDP1 is its ability to interact with DNA. This interaction allows BDP1 to regulate the activity of other proteins that are involved in the regulation of apoptosis. One of the most well-known of these proteins is Bcl-2, which is also a member of the Bcl-2 family. Bcl-2 is known for its ability to inhibit the activity of factors that promote apoptosis, and for its role in the regulation of apoptosis in various tissues.

BDP1 is also involved in the regulation of apoptosis in the brain. The brain is a particularly sensitive organ to the effects of apoptosis, and BDP1 is thought to play a role in the regulation of this process in the brain. Studies have shown that BDP1 is involved in the regulation of apoptosis in the brain, and that its activity may be influenced by factors such as stress, trauma, and neurodegenerative diseases.

In addition to its role in the regulation of apoptosis, BDP1 is also thought to be involved in the regulation of cell survival. This is suggested by the fact that BDP1 is often expressed in tissues that are naturally resistant to apoptosis, such as the spleen and the gastrointestinal tract. It is also shown that BDP1 is involved in the regulation of cell survival in various tissues, and that its activity may be influenced by factors such as nutrient availability and stress.

In conclusion, BDP1 is a protein that is involved in a variety of processes in the body, including the regulation of apoptosis. Its activity in these processes may be influenced by factors such as stress, trauma, and neurodegenerative diseases. Further research is needed to fully understand the role of BDP1 in these processes, and to determine its potential as a drug target or biomarker.

Protein Name: B Double Prime 1, Subunit Of RNA Polymerase III Transcription Initiation Factor IIIB

Functions: General activator of RNA polymerase III transcription. Requires for transcription from all three types of polymerase III promoters. Requires for transcription of genes with internal promoter elements and with promoter elements upstream of the initiation site

The "BDP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BDP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BEAN1 | BEAN1-AS1 | BECN1 | BECN2 | BEGAIN | BEND2 | BEND3 | BEND3P3 | BEND4 | BEND5 | BEND6 | BEND7 | BEST1 | BEST2 | BEST3 | BEST4 | BET1 | BET1L | beta-Adrenoceptor | beta-Crystallin | beta-Hexosaminidase Complex | beta-Secretase | BEX1 | BEX2 | BEX3 | BEX4 | BEX5 | BFAR | BFSP1 | BFSP2 | BFSP2-AS1 | BGLAP | BGLT3 | BGN | BHC complex | BHLHA15 | BHLHA9 | BHLHE22 | BHLHE22-AS1 | BHLHE23 | BHLHE40 | BHLHE40-AS1 | BHLHE41 | BHMT | BHMT2 | BICC1 | BICD1 | BICD2 | BICDL1 | BICDL2 | BICRA | BICRAL | BID | BIK | BIN1 | BIN2 | BIN3 | BIN3-IT1 | Biogenesis of lysosome-related organelles complex-1 | BIRC2 | BIRC3 | BIRC5 | BIRC6 | BIRC7 | BIRC8 | BISPR | BIVM | BIVM-ERCC5 | BLACAT1 | BLACE | BLCAP | BLID | BLK | BLM | BLMH | BLNK | BLOC-1 (biogenesis of lysosome-related organelles complex 1) | BLOC1S1 | BLOC1S1-RDH5 | BLOC1S2 | BLOC1S3 | BLOC1S4 | BLOC1S5 | BLOC1S5-TXNDC5 | BLOC1S6 | BLTP1 | BLTP2 | BLTP3A | BLTP3B | BLVRA | BLVRB | BLZF1 | BMAL1 | BMAL2 | BMAL2-AS1 | BMERB1 | BMF | BMI1 | BMP1 | BMP10